CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Authors
JF Andrade-Villanueva
K Arasteh
+34Â more
A Baumgarten
K Chow
H Crauwels
A Cutrell
R D'Amico
SL Ford
P-M Girard
M Gorgolas Hernandez-Mora
S Griffith
CM Harrington
KJ Hudson
G Latiff
DA Margolis
M Masia
JM Mrus
S Oka
C Orkin
ET Overton
P Patel
V Pokrovsky
GJ Richmond
G Rizzardini
J Roberts
KY Smith
WR Spreen
M St Clair
S Swindells
CL Talarico
V Van Eygen
R Van Solingen-Ristea
S Vanveggel
N Walters
A Wills
S Wu
Publication date
1 December 2020
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Supporting member
Queen Mary Research Online
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:qmro.qmul.ac.uk:123456789/...
Last time updated on 07/04/2021